Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | FPR3 | P25089 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4576643 | 0.93 | EPHX2 (0.41) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL28898948 | 0.91 | EPHX2 (0.43) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL1410283 | 0.86 | HDAC6 (0.37) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL134923 | 0.85 | EPHX2 (0.46) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL1639757 | 0.85 | TSHR (0.50) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL28792442 | 0.84 | EPHX2 (0.35) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL14482719 | 0.83 | EPHX2 (0.49) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL3914424 | 0.83 | EPHX2 (0.49) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| Hydrochloric Acid SCHEMBL7239543 | 0.83 | TSHR (0.48) | EPHX2TSHRHDAC8HDAC1HDAC2 | |
| SCHEMBL3251209 | 0.83 | EPHX2 (0.49) | EPHX2TSHRHDAC8HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112384493-A | Process for the preparation of fused tricyclic gamma-amino acid derivatives and intermediates | 四川海思科制药有限公司 | 2021-02-19 | — | — | CN | claimed |
| WO-2025126794-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025126793-A1 | METHOD FOR PRODUCING POLYCARBOXYLIC ACID ESTER COMPOUND | 本州化学工業株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-12037641-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| US-11833229-B2 | Labeling precursors with squaric acid coupling | SCV SPEZIAL-CHEMIKALIEN-VERTRIEBS GMBH (DE) | 2023-12-05 | — | — | US | disclosed |
| US-20230151017-A1 | THERAPEUTIC AGENTS TARGETING GPR35 | PROMETHEUS BIOSCIENCES, INC. | 2023-05-18 | — | — | US | disclosed |
| US-20220106254-A1 | MIGRATION-RESISTANT PHOTOPOLYMERIZATION SENSITIZER | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2022-04-07 | — | — | US | disclosed |
| CN-113166036-A | Photopolymerisable sensitizers having migration resistance | 川崎化成工业株式会社 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020209209-A1 | RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, RADICAL PHOTOPOLYMERIZABLE COMPOSITION CONTAINING RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, COATING CONTAINING RADICAL PHOTOCURING OXYGEN INHIBITION REDUCER, AND METHOD FOR CURING SAME | 川崎化成工業株式会社 | 2020-10-15 | — | — | WO | disclosed |
| US-6030746-A | CHEMICALLY AMPLIFIED POSITIVE RESIST COMPRISES A ORGANIC SOLVENT, AN ALKALI SOLUBLE RESIN, A PHOTOACID GENERATOR AND A DISSOLUTION RATE REGULATOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-02-29 | — | — | US | disclosed |
| WO-1998045275-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY | AXYS PHARMACEUTICALS CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| EP-0854869-A1 | SPIRO COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELET AGGREGATION | ELI LILLY AND COMPANY (US) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997011940-A1 | SPIRO COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELET AGGREGATION | ELI LILLY AND COMPANY (US) | 1997-04-03 | — | — | WO | disclosed |
| US-5532171-A | PHENOTHIAZINE DYES FOR PHOTODYNAMIC THERAPY OF CANCER OR IMMUNOASSAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5344928-A | Phenothiazine compounds for cancer treatment or immunoassay using chemiluminescence | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-06 | — | — | US | disclosed |
| EP-0510668-A2 | Phenothiazine derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-10-28 | — | — | EP | disclosed |
| EP-0055562-B1 | CEPHALOSPORIN DERIVATIVES | ICI PHARMA (FR) | 1986-02-12 | — | — | EP | disclosed |
| US-4492692-A | BACTERICIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-01-08 | — | — | US | disclosed |
| EP-0055562-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1982-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037641-B2 | Modified nucleotide reagents | POLL, POLN, POLM | EPHX2 3971/4885TSHR 3276/4885HDAC8 4228/4885 |
| US-20230151017-A1 | THERAPEUTIC AGENTS TARGETING GPR35 | GPR35, GPR68, GPR65 | EPHX2 3622/4885TSHR 1743/4885HDAC8 660/4885 |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | F12, F10, PCNA | EPHX2 1534/4885TSHR 2947/4885HDAC8 1396/4885 |
| US-20220106254-A1 | MIGRATION-RESISTANT PHOTOPOLYMERIZATION SENSITIZER | F12, F10, PCNA | EPHX2 1534/4885TSHR 2947/4885HDAC8 1396/4885 |
| US-11833229-B2 | Labeling precursors with squaric acid coupling | SCLY, SRRT, CS | EPHX2 4573/4885TSHR 149/4885HDAC8 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.